TWA
GSK icon

Tillar-Wenstrup Advisors’s GSK GSK Stock Holding History

Tillar-Wenstrup Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-42,101
Closed -$2.11M – 51
2018
Q3 		$2.11M Sell
42,101
-753
-2% -$38.3K 1.15% 36
2018
Q2 		$2.16M Sell
42,854
-1,496
-3% -$75.3K 1.2% 36
2018
Q1 		$2.17M Buy
+44,350
New +$2.07M 1.26% 32

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Tillar-Wenstrup Advisors's GSK Position: Q4 2018 in Review

Tillar-Wenstrup Advisors sold out of GSK (GSK) in Q4 2018, closing a stake of 42,101 shares — an estimated $2.11M sold.

Tillar-Wenstrup Advisors first reported a position in GSK in Q1 2018 and held it in 3 quarters. The position peaked at $2.17M in Q1 2018. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

  • Tillar-Wenstrup Advisors reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
  • Tillar-Wenstrup Advisors sold 42,101 GSK shares in Q4 2018, an estimated $2.11M.
  • Tillar-Wenstrup Advisors first reported a position in GSK in Q1 2018 and held it in 3 quarters.
  • Tillar-Wenstrup Advisors's GSK position peaked at $2.17M in Q1 2018.
  • 799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Tillar-Wenstrup Advisors's 13F filing for Q4 2018, filed 29 Jan 2019.